首页> 外国专利> QUINAZOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THE MANUFACTURE OF MEDICAMENTS HAVING AN ANTIANGIOGENIC AND/OR VASCULAR PERMEABILITY REDUCING EFFECT

QUINAZOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THE MANUFACTURE OF MEDICAMENTS HAVING AN ANTIANGIOGENIC AND/OR VASCULAR PERMEABILITY REDUCING EFFECT

机译:喹唑啉衍生物,其制备方法,包含它们的药物组合物及其在具有抗血管生成和/或血管渗透性降低作用的药物制备中的用途

摘要

The invention relates to the use of compounds of formula (I), wherein: ring C is a 5-6-membered heterocyclic moiety; Z is -O-, -NH-, -S- or -CH2-; R1 is hydrogen, C¿1-4?alkyl, C1-4alkoxymethyl, di(C1-4alkoxy)methyl, C1-4alkanoyl, trifluoromethyl, cyano, amino, C2-5alkenyl, C2-5alkynyl, carboxy, C3-7cycloalkyl,C3-7cycloalkyl C1-3alkyl, or an optionally substituted group selected from phenyl, benzyl, phenylC2-4alkyl and a 5-6-membered heterocyclic group; n is an integer from 0 to 5; m is an integer from 0 to 3; R?2¿ represents hydrogen, hydroxy, halogeno, cyano, nitro, trifluoromethyl, C¿1-3?alkyl, C1-3alkoxy, C1-3alkylsulphanyl, -NR?3R4¿ (wherein R?3 and R4¿, which may be the same or different, each represents hydrogen or C¿1-3?alkyl), or R?5X1¿- (wherein X1 represents a direct bond, -CH¿2?-, or a heteroatom linker group and R?5¿ is an alkyl, alkenyl or alkynyl chain optionally substituted by for example hydroxy, amino, nitro, alkyl, cycloalkyl, alkoxyalkyl, or an optionally substituted group selected from pyridone, phenyl and a heterocyclic ring, which alkyl, alkenyl or alkynyl chain may have a heteroatom linker group, or R5 is an optionally substituted group selected from pyridone, phenyl and a heterocyclic ring, and salts thereof, in the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals, processes for the preparation of such compounds, pharmaceutical compositions containing a compound of formula (I) or a pharmaceutically acceptable salt thereof as active ingredients and compounds of formula (I). The compounds of formula (I) and the pharmaceutically acceptable salts thereof inhibit the effects of VEGF, a property of value in the treatment of a number of disease states including cancer and rheumatoid arthritis.
机译:本发明涉及式(I)化合物的用途,其中:环C为5-6元杂环部分; Z为-O-,-NH-,-S-或-CH 2-; R 1是氢,C 1-4烷基,C 1-4烷氧基甲基,二(C 1-4烷氧基)甲基,C 1-4烷酰基,三氟甲基,氰基,氨基,C 2-5烯基,C 2-5炔基,羧基,C 3-7环烷基,C 3- 7个环烷基C 1-3烷基,或选自苯基,苄基,苯基C 2-4烷基和5-6元杂环基的任选取代的基团; n是0至5的整数; m是0至3的整数; R 2代表氢,羟基,卤代,氰基,硝基,三氟甲基,C 1-3烷基,C 1-3烷氧基,C 1-3烷基磺酰基,-NR 3 R 4 R(其中R 3和R 4可以是相同或不同,分别代表氢或C 1-3烷基)或R 5X1 -(其中X 1代表直接键,-CH 2或杂原子连接基团,R 5′为任选地被例如羟基,氨基,硝基,烷基,环烷基,烷氧基烷基或选自吡啶酮,苯基和杂环的任选取代的基团的烷基,烯基或炔基链,其中烷基,烯基或炔基链可具有杂原子在制备用于在温血动物中产生抗血管生成和/或降低血管通透性的作用的药物的制备中,接头基团或R 5是选自吡啶酮,苯基和杂环及其盐的任选取代的基团,制备此类化合物的方法,含有下式化合物的药物组合物(I)或其药学上可接受的盐作为活性成分和式(I)化合物。式(I)的化合物及其药学上可接受的盐抑制VEGF的作用,这是治疗包括癌症和类风湿性关节炎在内的多种疾病的有价值的特性。

著录项

  • 公开/公告号IL142359B

    专利类型

  • 公开/公告日2008-11-03

    原文格式PDF

  • 申请/专利权人 ASTRAZENECA AB;

    申请/专利号IL142359

  • 发明设计人

    申请日2001-04-01

  • 分类号A61K31/505;A61K31/517;A61K31/5377;A61P3/10;A61P9/00;A61P9/10;A61P9/14;A61P13/12;A61P15/00;A61P27/02;A61P29/00;A61P31/00;A61P35/00;A61P37/02;C07B61/00;C07D401/12;C07D401/14;C07D403/12;C07D403/14;C07D405/12;C07D405/14;C07D413/12;C07D417/12;C07D521/00;

  • 国家 IL

  • 入库时间 2022-08-21 20:08:03

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号